Clinical pharmacokinetics of morphine

Clinical pharmacokinetics of morphine

Lugo RA; Kern SE

Journal of Pain and Palliative Care Pharmacotherapy

2002

Child; Humans; infant; Adult; Aged; Drug Interactions; Biotransformation; Half-Life; Tissue Distribution; infant; Administration; Newborn; Oral; Injections; Intravenous; Delayed-Action Preparations; Aging/metabolism; Metabolic Clearance Rate; Dosage Forms; Intestinal Absorption; Morphine/administration & dosage/metabolism/pharmacokinetics; Neoplasms/metabolism

Morphine, the most widely used mu-opioid analgesic for acute and chronic pain, is the standard against which new analgesics are measured. A thorough understanding of the pharmacokinetics of morphine is required in order to safely and effectively use this analgesic in a wide variety of patients with different levels of organ function. A MEDLINE search was conducted to identify literature published between 1966 and January 2002 relevant to the pharmacokinetics of morphine. These publications were reviewed and the literature summarized regarding unique and clinically important elements of morphine disposition relative to its parenteral administration (including intravenous, intramuscular, subcutaneous, epidural and intrathecal administration), absorption profile (immediate release, controlled release, and sublingual/buccal, and rectal administration), distribution, and its metabolism/excretion. Special populations, including infants, elderly, and those with renal/liver failure, have a unique morphine pharmacokinetic profile that must be taken into account in order to maximize analgesic efficacy and reduce the risk of adverse events.

2002

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog